BackBioTech Medics Overview

BioTech Medics Current Cash

Latest current cash for BMCS: $-300.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$-302.00
↓ 102.81% YoYΔ $-11059.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioTech Medics Current Cash History

Loading

BioTech Medics vs. peers: Current Cash Comparison

Loading

BioTech Medics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioTech Medics (BMCS) FAQ

BioTech Medics posts a current cash of $-300 as of March 2025. That compares with $11K in the prior-year period — down 102.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BioTech Medics's current cash was $11K. The latest reading is $-300 — a 102.8% year-over-year decrease (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of BioTech Medics's financial statement story. At $-300, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BMCS's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BioTech Medics's other metric pages and overview cover the third.